Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study).

Autor: Pedersen ED; Akershus University Hospital, Department of Neurology, Loerenskog, Norway.; Sandvika Nevrosenter, Sandvika, Norway., Stenager E; MS Clinic of Southern Jutland, Department of Neurology, Hospital of Southern Denmark, Odense, Denmark.; Institute of Regional Research, University of Southern Denmark, Odense, Denmark., Vadgaard JL; Department of Neurology, Sjællands University Hospital, Roskilde NeuroCenter, Roskilde, Denmark., Jensen MB; Department of Neurology, Nordsjaellands Hospital, Hilleroed, Denmark., Schmid R; MS Clinic, Department of Neurology, Vejle Hospital, Vejle, Denmark., Meland N; Smerud Medical Research, Oslo, Norway., Magnussen G; Merck Norway, An Affiliate of Merck AB (Merck AB NUF), Oslo, Norway., Frederiksen JL; Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Science, Glostrup, Denmark.; Institute of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

Publikováno v: Patient preference and adherence [Patient Prefer Adherence] 2018 Apr 19; Vol. 12, pp. 569-575. Date of Electronic Publication: 2018 Apr 19 (Print Publication: 2018).